InvestorsObserver
×
News Home

What is the Market's View on Tenaya Therapeutics Inc (TNYA) Stock's Price and Volume Trends Friday?

Friday, October 06, 2023 03:31 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Tenaya Therapeutics Inc (TNYA) Stock's Price and Volume Trends Friday?

Tenaya Therapeutics Inc (TNYA) stock is unchanged 0.00% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
Tenaya Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TNYA!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With TNYA Stock Today?

Tenaya Therapeutics Inc (TNYA) stock is trading at $2.55 as of 3:21 PM on Friday, Oct 6, an increase of $0.35, or 15.68% from the previous closing price of $2.20. The stock has traded between $2.25 and $2.59 so far today. Volume today is above average. So far 578,124 shares have traded compared to average volume of 392,381 shares.

More About Tenaya Therapeutics Inc

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. Click Here to get the full Stock Report for Tenaya Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App